Healthcare Sep 13, 2021 09:26 AM (GMT+8) · EqualOcean
Yiouda health learned on the 13th that recently, Shenzhen lancet robot Co., Ltd. (hereinafter referred to as "Lancet robot") announced that it had completed a new round of financing of tens of millions of yuan, which was invested by the small and medium-sized enterprise development fund managed by Dongfang Fuhai. The financing income will be mainly used for the clinical research and new product research and development of many surgical robots of the company. Previously, the lancet robot has successively completed the angel round financing jointly invested by Yuansheng venture capital and the former sea mother fund and the pre-A round financing invested by Haibang Fenghua. The lancet robot was founded in July 2018, focusing on the innovation of intelligent orthopaedic surgery solutions, and is committed to realizing the intelligence, minimally invasive and precision of orthopaedic surgery. Its core founding team members are from well-known universities such as Tsinghua University, Harbin Institute of technology, Shanghai Jiaotong University and National Taiwan University, and have rich experience in the field of surgical robot R & D. At present, the lancet hip arthroplasty robot has successfully performed robot assisted hip arthroplasty in many well-known third-class hospitals, including the Gulou Hospital Affiliated to the Medical College of Nanjing University. In addition, robpath, a total knee arthroplasty robot independently developed by lancet robot, has also launched a Chinese registered clinical trial.